Element Capital Management LLC Nektar Therapeutics Transaction History

Element Capital Management LLC

  • $151 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 12, 2020
SELL
$15.87 - $23.12 $596,632 - $869,196
-37,595 Closed
0 $0
Q3 2019

Nov 12, 2019
BUY
$16.91 - $36.27 $635,731 - $1.36 Million
37,595 New
37,595 $685,000
Q4 2018

Feb 13, 2019
SELL
$30.43 - $56.65 $2.85 Million - $5.3 Million
-93,537 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$46.46 - $68.49 $4.35 Million - $6.41 Million
93,537 New
93,537 $5.7 Million

Others Institutions Holding NKTR

# of Institutions
128
Shares Held
111M
Call Options Held
150K
Put Options Held
4K
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $219M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Element Capital Management LLC Portfolio

Follow Element Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Element Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Element Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email